Skip to Main Content (Press Enter)
×
Home
Persone
Pubblicazioni
Facoltà
Ambiti Di Ricerca
IT
EN
☰
UNIFIND
|
UNIFIND
unisr.it
IT
EN
×
Home
Persone
Pubblicazioni
Facoltà
Ambiti Di Ricerca
☰
Pubblicazioni
THE ONCOLOGIST
Rivista
Codice:
E125377
ISSN:
1083-7159
Dati Generali
Dati Generali
Pubblicazioni (29)
Pulisci
Ordina Pubblicazioni:
ascendente
decrescente
A reappraisal of the diagnostic and therapeutic management of uncommon histologies of primary ocular adnexal lymphoma
Articolo
Advanced Squamous Cell Carcinomas of the Pelvic and Perineal Region: A Comprehensive Genomic Profiling Study
Articolo
BREAST CANCER GENOMICS: CHALLENGES IN INTERPRETATION AND APPLICATION
Articolo
Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study
Articolo
Characterization of the safety profile of trastuzumab deruxtecan by dose: a pooled analysis across DESTINY studies
Articolo
Chemotherapy Dose Adjustment for Obese Patients Undergoing Hematopoietic Stem Cell Transplantation: A Survey on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Articolo
Clinical Relevance of the Dose of Cytarabine in the Upfront Treatment of Primary CNS Lymphomas with Methotrexate-Cytarabine Combination
Articolo
Clinical Usefulness of 18F-Fluorodeoxyglucose Positron Emission Tomography in the Diagnostic Algorithm of Advanced Entero-Pancreatic Neuroendocrine Neoplasms
Articolo
Clinical features, management, and prognosis of an international series of 161 patients with limited-stage diffuse large B-cell lymphoma of the bone (the IELSG-14 study)
Articolo
DNA REPAIR GENE PATTERNS AS PROGNOSTIC AND PREDICTIVE FACTORS IN MOLECULAR BREAST CANCER SUBTYPES
Articolo
Delphi consensus on the management of adverse events in patients with metastatic triple-negative breast cancer treated with sacituzumab govitecan
Articolo
Efficacy of Platinum Rechallenge in Metastatic Urothelial Carcinoma After Previous Platinum-Based Chemotherapy for Metastatic Disease
Articolo
Efficacy of cisplatin-gemcitabine-durvalumab in patients with advanced biliary tract cancer experiencing early vs late disease relapse after surgery: a large real-life worldwide population
Articolo
Genomic Features for Therapeutic Insights of Chemotherapy-Resistant, Primary Mediastinal Nonseminomatous Germ Cell Tumors and Comparison with Gonadal Counterpart
Articolo
Guillain-Barré Syndrome During Platinum-Based Chemotherapy: A Case Series and Review of the Literature
Articolo
Hyperprogression and Immune Checkpoint Inhibitors: Hype or Progress?
Articolo
Personalized Risk–Benefit Ratio Adaptation of Breast Cancer Care at the Epicenter of COVID-19 Outbreak
Articolo
Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating Lymphocytes
Articolo
Pretreatment Blood Parameters Predict Efficacy from Immunotherapy Agents in Early Phase Clinical Trials
Articolo
Prevalence of Borrelia Burgdorferi Infection in a Series of 98 Primary Cutaneous Lymphomas
Articolo
Prolonged pemetrexed infusion plus gemcitabine in refractory metastatic colorectal cancer: Preclinical rationale and phase II study results
Articolo
Prophylaxis, clinical management, and monitoring of datopotamab deruxtecan-associated oral mucositis/stomatitis
Articolo
Real-world study of everolimus in advanced progressive neuroendocrine tumors
Articolo
Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single-Arm, Open-Label Phase IIIb CONSIGN Study
Articolo
Stage IV Gastro-Entero Pancreatic Neuroendocrine Neoplasms: A Risk Score to Predict Clinical Outcome
Articolo
TP53 Alterations Are Associated With Poor Survival in Patients With Primary Mediastinal Nonseminoma Germ Cell Tumors
Articolo
The Impact of Cisplatin- or Non-Cisplatin-Containing Chemotherapy on Long-Term and Conditional Survival of Patients with Advanced Urinary Tract Cancer
Articolo
The role of HER-3 expression in the prediction of clinical outcome for advanced colorectal cancer patients receiving irinotecan and cetuximab
Articolo
Tumor response and symptom palliation from rainbow, a phase III trial of ramucirumab plus paclitaxel in previously treated advanced gastric cancer
Articolo
No Results Found
«
‹
{pageNumber}
›
»
{startItem} - {endItem} di {itemsNumber}
5 per pagina
10 per pagina
30 per pagina
vedi tutti
